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A B S T R A C T   
Introduction: The emergence of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) had resulted 
in an unpresented global pandemic. In the initial events, the Kingdom of Saudi Arabia implemented mandatory 
quarantine of returning travelers in order to contain COVID-19 cases. 
Materials and methods: This is a longitudinal study of the arriving travelers to Quarantine facilities and the 
prevalence of positive SARS-CoV-2 as detected by RT-PCR. 
Results: During the study period, there was a total of 1928 returning travelers with 1273 (66%) males. The age 
range was 28 days–69 years. Of all the travelers, 23 (1.2%) tested positive for SARS-CoV-2. Of the first swab, 14/ 
1928 (0.7%) tested positive. The positivity rate was 0.63% and 0.92% among males and females, respectively (P 
= 0.57). The second swab was positive in 9 (0.5%) of the other 1914 who were initially negative with a positivity 
rate of 0.39% and 0.62% among males and females, respectively (P = 0.49). There was no statistical difference in 
the positivity rates between first and second swab (P = 0.4). Of all travelers, 40 (n = 26, 1.3%) were admitted 
from the quarantine facility to the hospital due to COVID-19 related positive results or development of symptoms 
such as fever, cough, and respiratory symptoms; and 14 (0.7%) were admitted due to non-COVID-19 related 
illness. 
Conclusion: This study showed the efforts put for facility quarantine and that such activity yielded a lower 
incidence of positive cases. There was a need to have a backup healthcare facility to accommodate those 
developing a medical need for evaluation and admission for non-COVID-19 related illnesses.   
1. Introduction 
The emergence of the Severe Acute Respiratory Syndrome Corona-
virus 2 (SARS-CoV-2) had resulted in an unpresented global pandemic. 
SARS-CoV-2, the causative agent of the Coronavirus Disease 2019 
(COVID-19) had been associated with asymptomatic infection [1]. 
Initial reported cases of COVID-19 in the Gulf region were among 
travelers who came from Iran and Iraq to Bahrain and Kuwait. The first 
case of the COVID-19 infection in Saudi Arabia was in Qatif city, in the 
Eastern province and was reported in a person who came from Iran [2, 
3]. The case was reported on March 2nd, 2020 and 51 contacts tested 
negative for SARS-CoV-2 [3]. The Kingdom of Saudi Arabia had taken 
extensive preemptive strategies to curtain the development of COVID-19 
[3–5]. As initial cases being reported in KSA, there were multiple in-
terventions to control the spread of the virus and included: cancellation 
of events with the potential for a superspreading events such as mass 
gathering events, citywide festivals, religious gatherings, cultural cele-
brations and scientific conferences [3]. On 27 February 2020, visits to 
Makkah for the mini-pilgrimage (Umrah) was suspended [6]. In addi-
tion, there was curfew implementation in various cities with time being 
adjusted to the number of reported cases [3]. It is important to point out 
that the first case of COVID-19 in KSA was announced on March 2nd, 
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2020 in a citizen returning from Iran in the Qatif region, Eastern KSA, 
and 51 contacts tested negative [3]. Subsequently, the cumulative 
numbers of cases were 104 on March 14, 7142 on April 14, 54752 on 
May 17, and 335578 on October 2, 2020. 
All international flights were suspended on March 15, 2020 and all 
returning travelers were required to have a two-week quarantine in 
dedicated quarantine facilities. Quarantine is one of the methods to 
control the spread of emerging infectious diseases and is the process of 
separating or restricting movement of exposed non-infected individuals 
for the duration of the incubation period [7]. The word “quarantine” 
originates from the Latin “quadragina” or the Italian “quaranta”, 
meaning 40 and refers to sailors who were observed for 40 days before 
disembarkation ships during the bubonic and pneumonic plague [8]. 
Governmental quarantine facilities were utilized during the SARS 
outbreak and individuals needing quarantine were hosted in individual 
rooms and meals were provided to them [8]. In Hong Kong, 131132 
persons (50319 close contacts and 80813 travelers) were placed in 
quarantine [8]. The process of quarantine was also used for exposed 
healthcare workers during MERS-CoV and SARS [9,10]. The Kingdom of 
Saudi Arabia implemented flight restrictions in order to contain the 
spread of SARS-CoV-2. Passengers arriving on March 6th, 2020 forward 
and were coming from high-risk countries had been placed in mandatory 
Government Quarantine facilities. Johns Hopkins Aramco Healthcare 
(JHAH), a fully integrated health system which provides medical 
coverage to the employees of Saudi Aramco, the world’s largest Energy 
Company, elected to run Quarantine facilities for its returning em-
ployees. JHAH was responsible for a total of 7 Quarantine facilities 
between March 14th and June 7, 2020. These were a combination of 
International Chain hotels and Saudi Aramco owned Apartments. Here, 
we present this experience and calculate the incidence of 
travel-associated COVID-19 infection among returning travelers. 
2. Materials and Methods 
Saudi Aramco had a sizeable population outside the Kingdom of 
Saudi Arabia at the time of Travel restrictions. These included em-
ployees working on Joint Ventures, attending conferences and business 
meetings and both Undergraduate and Postgraduate Students. Em-
ployees on long term assignments were also accompanied with their 
families. There were additionally patients who were abroad receiving 
medical treatment. 
Johns Hopkins Aramco Healthcare (JHAH) established in 
coordination with the Saudi Ministry of Health (MOH) quarantine fa-
cilities to host returning travelers. The quarantine facilities required 
extensive multidisciplinary efforts (Fig. 1). JHAH provided the provision 
of 24-h coverage and administrative support to these facilities. There 
were over 140 staff involved including physicians, nurses and admin-
istration (Fig. 1). 
There were cyclical peaks of resources needed to manage the 
workflow. The peaks of the work were at admission, swabbing and 
discharge (Fig. 2). There were multiple admission dates and thus there 
were multiple stages of the cycle simultaneously occurring. The first 
batch of travelers (n = 118) arrived at the Quarantine facilities on March 
14, 2020. However, these travelers had already been in the Kingdom in 
Government operated Quarantine facilities with a varying stay from 1 to 
6 days in duration. All travelers from 14th March 2020 onwards came 
directly to the JHAH Quarantine facilities (Fig. 3). Prior to the opening 
of these facilities, there were thorough assessments of the sites coupled 
Fig. 1. A diagram showing the different multidisciplinary Efforts in the Quarantine Facilities.  
Fig. 2. A diagram showing the cyclical peaks of needed resources at the 
Quarantine Facilities. The X-axis shows the days of Quarantine. 
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with ensuring the availability of medical staff in each facility. Infection 
control teams visited these sites and intensive education was conducted 
for all medical staff and for housekeeping personnel on waste disposal. 
A small number of the returning travelers were repatriated to Saudi 
Arabia in the last Scheduled flights returning before the travel ban came 
into effect. All of those travelers arrived from high risk countries such as 
Italy, Spain and the USA. The arriving travelers were predominantly 
employees returning from Europe and the others were students and 
those who were abroad for medical treatments. All those travelers were 
subject to a mandatory two-week quarantine with the requirement of 
nasopharyngeal and oropharyngeal swab at the beginning of arrival and 
before the conclusion of the quarantine period. Travelers arriving after 
May 7th, 2020 were allowed to complete one week of facility quarantine 
followed by an additional week of home quarantine, monitored by 
Mobile phone tracking to ensure compliance. 
Travelers arrived from USA, United Kingdom, Spain, Italy, Canada, 
Egypt, Dubai, Oman and Bahrain. Those that came from Bahrain had 
originally come from other parts of the world but were transiting 
through Bahrain. They had not been allowed to travel onwards and were 
subject to 2 weeks of government Quarantine in Bahrain before arriving 
in Saudi Arabia by buses, ensuring universal masking and social 
distancing, through the King Fahad causeway (joining Bahrain and 
Saudi Arabia). All other travelers had arrived by airplane and were 
brought from the airport directly to the facility utilizing specifically 
designated buses fulfilling the requirement of social distancing and 
universal masking. 
The day of Arrival was considered as Day “0” of the clinical course. 
Each arriving traveler was visually triaged for fever and other respira-
tory symptoms. Those who reported any such symptoms were admitted 
to the hospital for further observation and management. Those who had 
no symptoms on screening were checked into individual rooms and had 
both Nasopharyngeal and Oropharyngeal swabs testing for SARS-CoV- 
2within 24 h of arrival for COVID 19. 
There were strict Quarantine protocols, with guest not being allowed 
out of their rooms except in case of an emergency. Guests were moni-
tored twice a day for temperature and the development of any respira-
tory symptoms. If any guest developed symptoms then the guest was 
transferred to hospital for management and retesting. The guest would 
remain in the hospital until symptoms resolve and there is a negative 
PCR test for SARS-CoV-2 and then he/she was sent back to the quar-
antine facility. If the SARS-CoV-2 PCR test turned to be positive, the 
guest was transferred to JHAH Hospital. The Quarantine facility had 24 
h medical coverage from a multidisciplinary team. They were able to 
address all COVID-19 and non-COVID-19 related medical issues. 
Travelers were retested pre-discharge by repeating the swab on day 
12 or day 13 of their stay. If the results were negative, they were 
discharged on Day 14 from the Quarantine facilities back into the 
community. If they tested positive, they were admitted to JHAH 
hospital. 
The diagnosis of SARS-CoV-2 infection was based on real-time 
reverse-transcriptase–polymerase-chain-reaction (RT-PCR) assay as 
described previously [2,11]. We analyzed the presentation and inci-
dence of COVID-19. We also collected the demographic, age, gender, 
country and date of arrival to the Kingdom and SARS-CoV-2 RT-PCR 
results for all 1928 travelers. 
3. Results 
During the study period, there was a total of 1928 returning travelers 
with 1273 (66%) males. The age range was 28 days–69 years and the 
highest number 1020 (52.9%) were 20-29 years of age (Fig. 4 and 
Table 1). Of the travelers, 23 (1.2%) tested positive. Of the first swab, 
14/1928 (0.7%) tested positive. The positivity rate was 0.63% and 
0.92% among males and females, respectively (P = 0.57) (Fig. 5). The 
second swab was positive in 9 (0.5%) of the other 1914 who were 
initially negative with a positivity rate of 0.39% and 0.62% among males 
and females, respectively (P = 0.49). There was no statistical difference 
in the positivity rates between first and second swab (P = 0.4). Table 2 
shows the incidence rate (%) of positive samples according to the age 
range (in years). The Quarantine activity satrted on March 6th, 2020 and 
in the 1st four weeks of the Quarantine the prevalence of COVID-19 
positivity was 5.9% (Table 3). After that, the incidence steady 
declined and no further new cases were detected after the eighth week. 
On the other hand, the prevalence of positive SARS-CoV-2 cases 
decreased overtime due to increasing number of guests and lower inci-
dence of travel-associated cases (Table 3). 
The country of origin of positive 1st swab was predominantly among 
those returning from the United Kingdom (11/14, 79%) then those from 
Bahrain (2/14, 14%) and 7% (1/14) from USA. Travelers from Bahrain 
had spent a minimum of 2 weeks of Quarantine in Bahrain after arriving 
from the UK and USA. They were considered as having originated from 
Bahrain for this reason. The two cases that tested positive after arriving 
from Bahrain had both originated from the UK, giving UK 93% of all 
positive travelers. 
Of all travelers, 40 (n = 26, 1.3%) were admitted from the quarantine 
to the hospital due to COVID-19 related positive results or development 
of symptoms such as fever, cough, and respiratory symptoms (Table 1). 
In addition, 14 (0.7%) were admitted due to non-COVID-19 related 
illness such as diabetic ketoacidosis (new onset type 1 diabetes mellitus), 
appendicitis, fracture, dental abscess, neonatal sepsis, sickle cell vaso- 
occlusive crisis, thrombosed piles, anxiety attack, depression, vaso-
vagal attack, and pregnancy-associated nausea. Moreover, there were 
Fig. 3. Timeline of Arriving Travelers into the Quarantine Facilities.  
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instances of the occurrence of minor illnesses such as: gastroenteritis, 
vertigo, otitis externa, the need to adjust medications, epistaxis, and 
burn injuries. These minor issues were tackled by the medical team on 
the quarantine facilities with no need for hospital transfer. 
4. Discussion 
In this study, we described our experience with opening and running 
quarantine facilities for returning travelers who were hosted for COVID- 
19 evaluation. The experience involved medical and non-medical care 
and highlighted the needed logistics. We had shown that the prevalence 
of COVID-19 among returning travelers to KSA and who were admitted 
to a quarantine facility was relatively low and was 1.2%. The initial 
swabs gave a positivity rate of 0.7% among 1928 returning travelers. A 
previous study of 337 passengers, none of them tested positive at day 
0 and day 5 [12]. The low rate of positive SARS-CoV-2 tests of returning 
travelers suggest that the strategy of 14-days quarantine needs to be 
Fig. 4. A bar-graph showing the distribution of the age group of returning travelers.  
Table 1 
A summary of the results of the swabs of returning travelers.  
Total Number of Guests 1928 
Gender 66% Male 34% Female 
Age Range 28 Days to 59 Years 
Number of positive 1st Swab from all swabs 14/1928 (0.7%) 
Number of positive 2nd swab from all swabs September 1914 (0.5%) 
Number of any positive swab from all swabs 23/1928 (1.2%) 
Number (%) of admissions from the total 
1928 guests 
40 (2.1%) all admissions 
26 (1.3%) for COVID-19 related 
issues 
14 (0.7%) for non-COVID-19 related 
issuses  
Fig. 5. The Positivity Rate of SARS-CoV-2 RT-PCR among Returning Travelers according to the 1st and 2nd Swab among males, females, and all travelers.  
Table 2 
Age Range and Incidence Rates (%) of Positive Samples in each age group range 





Number (%) 1st Swab 
Positive 
Number (%) 2nd Swab 
Positive 
0–9 162 1 (0.6) 0 (0) 
10–19 375 3 (0.8) 1 (0.3) 
20–29 1020 3 (0.3) 5 (0.5) 
30–39 237 3 (1.3) 2 (0.8) 
40–49 74 3 (4.1) 1 (1.4) 
50–59 50 1 (2) 0 (0) 
60–69 10 0 (0) 0 (0)  
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revisited. Travelers arriving KSA after May 7th, 2020 were allowed to 
complete one week of facility quarantine followed by an additional week 
of home quarantine, monitored by Mobile phone tracking to ensure 
compliance. In addition, the policy in KSA had changed to a seven-day 
quarantine for the general population and a three-day quarantine with 
a PCR test. Further enhancement of the protocol is being considered to 
include a laboratory-based strategy to rule out positive SARS-CoV-2 and 
away from a time-based strategy of 14-days quarantine. In addition, 
there are increased thoughts to have salivary SARS-CoV-2 test to facil-
itate travel. These tests could be done at the airport with a rapid 
turn-around-time of the salivary tests. Developing rapid point of care 
tests for SARS-CoV-2 would further enhance the ability of travelers to 
easily travel [13]. In a meta-analysis, SARS-CoV-2 saliva tests had a 
sensitivity of 91% (CI 80–99%) vs. 98% (CI 89–100%) for nasopharyn-
geal swab [14]. An additional point-of-care test could utilize 
SARS-CoV-2 antigen for travelers and currently approved devices give 
results in about 15 min. However, antigen tests for SARS-CoV-2 are less 
sensitive than RT-PCR tests [15]. 
In this study, the majority of travelers where male with a 2:1 ratio, 
however, there was no statistical difference in the positivity rate be-
tween male and females. This finding is consistent with data that show 
no difference in the susceptibility to COVID-19 among males and fe-
males [16]. We observed that 9 travelers tested positive at day 12 of 
arrival and had initial negative 1st Swab. This is consistent with known 
incubation period of 2.1–11.1 days [17] and may represent the sensi-
tivity of the PCR test of around 70% from a single swab [18] or the 
presence of asymptomatic individuals who may had positive PCR test 
after the initial swab but were not detected till a repat swab was done at 
the end of the quarntine period [19]. 
The majority of patients had asymptomatic presentation (11/14; 
79%) and those with symptoms (3/14; 21%) only showed mild upper 
respiratory tract infection. It had been shown that asymptomatic SARS- 
CoV-2 infection is variable and was 17% among household contacts 
[20], 17.4% among children in a meta-analysis [21], and 10% of 100 
SARS-COV-2 patients in Taiwan [22]. In one study, asymptomatic pa-
tients were more likely to be present among those <45 years of age but 
could occur at any age [23]. 
The majority of positive cases in this study originated from the UK 
(93%). This is likely secondary to the fact that the peak of UK cases 
occurred late April-early May 2020 and that the cases had not yet 
peaked in the other countries. The Quarantine began on March 6th, 
2020 and in the 1st four weeks of the Quarantine the prevalence of 
COVID-19 positivity was 5.9%. Then the incidence steady declined up to 
8 weeks after the start of the Quarantine. After this time the prevalence 
became static at 1.4% with no new cases. This finding may reflect the 
benefits of worldwide lockdown measures coming into existence over 
this time period and possibly individuals taking more precautions at the 
country of travel as the disease became more prevalent. Early during the 
emergence of COVID-19 pandemic, travel-associated SARS-COV-2 
infection was taken seriously across the globe. In Germany, COVID-19 
outbreak was linked to a travelers from China [22]. In one study, one 
of 76 (1.3%) quarantined travelers tested positive for SARS-CoV-2 [24]. 
The occurrence of travel-associated cases was coupled with enhanced 
contact screening in multiple countries such as the USA [25]. Thus, one 
important measure to delay the introduction of COVID-19 or any other 
newly emerging infectious disease to a country or area or to delay the 
peak of an epidemic in areas with local transmission is the application of 
quarantine measures early in an outbreak as suggested by the World 
Health Organization [26]. Thus, the Kingdom of Saudi Arabia took these 
measures early on in the COVID-19 pandemic. A similar strategy of 
mandatory 14-day quarantine for incoming travelers were implemented 
in Hong Kong for those coming from affected areas [26]. Subsequently, 
such measures were relaxed and now KSA requires a seven-day home 
quarantine for asymptomatic returning travelers. In a mathematical 
model, screening of travelers at port-of-entry utilizing clinical features 
as well as for those coming from COVID-19-affected countries has 
modest delay in the introduction of the SARS-CoV-2 into any community 
[27]. A meta-analysis showed that quarantine of exposed individuals 
prevented 44–81% incident cases and 31–63% of deaths compared to no 
measures and there was very low-certainty evidence suggesting earlier 
quarantine measures are associated with greater cost savings [27]. 
However, the meta-analysis did not address returning travelers per se. 
Only 0.7% of travelers became unwell and required hospital ad-
missions for non-COVID-19 related illnesses such as Diabetic Ketoaci-
dois, appendicitis and foot fracture. This highlights the need to have 
access to medical care at any quarantine facility. We are fortunate to 
have all our guest as part of our electronic medical record and we were 
able to connect to these records. Other institutes may find this link of 
medical record challenging and requires contacting the primary care 
physicians or the healthcare providers with difficulty in such process 
[28] and thius may delay medical care. 
In conclusion, this study showed the efforts put for establishing and 
managing facilities for quarantine and that such activity yielded a lower 
incidence of positive cases with increasing global cases. There was a 
need to have a backup healthcare facility to accommodate those 
developing medical needs for evaluation and admission for COVID-19 as 
well as non-COVID-19 related illnesses. 
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